Olmesartan Medoxomil And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 70518-4517

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil And Hydrochlorothiazide (NDC 70518-4517). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Packaging label for Olmesartan Medoxomil and Hydrochlorothiazide tablet, film coated, 40 mg / 12.5 mg strength. The label shows a quantity of 90 tablets. Manufacturer is RemedyRepack Inc., Indiana, PA, with original manufacturing by Macleods Pharma, Baddi, India. Includes storage instructions and a caution to keep out of reach of children.*
FDA Label Image

505 (Olmesartan Hctz Structure)

505 (Olmesartan Hctz Structure)
Chemical structure diagram of Olmesartan Medoxomil, showing molecular components including sulfonamide groups, a chloro-substituted aromatic ring, and a cyclic amide. This illustration corresponds to the active ingredient Olmesartan Medoxomil in the product Olmesartan Medoxomil and Hydrochlorothiazide tablets.*
FDA Label Image

505 (Olmesartan Structure)

505 (Olmesartan Structure)
Chemical structure of Olmesartan Medoxomil, illustrating its molecular configuration with multiple rings and functional groups as depicted in the image provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.